← Back to Search

LCC Package with text-only warning and no flavor for Tobacco Use

N/A
Waitlist Available
Led By Adam O Goldstein
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants will be recruited through flyers, emails, and recruitment websites to identify potentially eligible participants local to our study location (Chapel Hill/Carrboro, NC)
* Over 21 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Summary

The goal of this research is to determine how removal of little cigar and cigarillo (LCC) flavor descriptors on packaging impacts attention and affective responses to LCC warnings. A study will be conducted using eye tracking, electrodermal activity (galvanic skin response), and survey measures of affect to measure participant responses to LCC packages varied by warning type (pictorial vs. text only) and flavor contents ('Sweet' flavor descriptor vs. no flavor descriptor).

Who is the study for?
This trial is for individuals who use tobacco products. Participants will be involved in a study that uses eye tracking and other measures to see how they react to different types of warnings on little cigar and cigarillo packages.
What is being tested?
The study is testing reactions to four combinations of package warnings: pictures with no flavor, text-only with 'sweet' flavor, text-only with no flavor, and pictures with 'sweet' flavor. The goal is to understand the impact on attention and feelings towards these warnings.
What are the potential side effects?
There are generally no direct side effects from participating in this type of behavioral study as it involves observation through eye-tracking and response measurements rather than medical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Attention to flavor area of interest
Attention to warning areas of interest
Secondary study objectives
Affective response to warnings
Electrodermal activity

Trial Design

4Treatment groups
Experimental Treatment
Group I: LCC Package with text-only warning and no flavorExperimental Treatment1 Intervention
Participants will see a mock LCC package with text-only warnings and no flavor descriptor.
Group II: LCC Package with text-only warning and 'sweet' flavorExperimental Treatment1 Intervention
Participants will see a mock LCC package with text-only warnings and a 'sweet' flavor descriptor
Group III: LCC Package with pictorial warning and no flavorExperimental Treatment1 Intervention
Participants will see a mock LCC package with pictorial warnings and no flavor descriptor.
Group IV: LCC Package with pictorial warning and 'sweet' flavorExperimental Treatment1 Intervention
Participants will see a mock LCC package with pictorial warnings and a 'sweet' flavor descriptor.

Find a Location

Who is running the clinical trial?

Food and Drug Administration (FDA)FED
176 Previous Clinical Trials
1,543,692 Total Patients Enrolled
4 Trials studying Tobacco Use
912 Patients Enrolled for Tobacco Use
National Cancer Institute (NCI)NIH
13,789 Previous Clinical Trials
40,986,195 Total Patients Enrolled
17 Trials studying Tobacco Use
10,192 Patients Enrolled for Tobacco Use
UNC Lineberger Comprehensive Cancer CenterLead Sponsor
357 Previous Clinical Trials
91,598 Total Patients Enrolled
1 Trials studying Tobacco Use
1,029 Patients Enrolled for Tobacco Use
~33 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top